Skip to main content

Table 1 Baseline characteristics

From: Pulmonary challenge with carbon nanoparticles induces a dose-dependent increase in circulating leukocytes in healthy males

 

Placebo (n = 9)

10 μg NP (n = 4)

50 μg NP (n = 4)

100 μg NP (n = 9)

P-value

Age, Yeara

26.0 (22–30)

26.0 (26–27)

21.5 (20–31)

24.0 (19–35)

0.70

FEV1, Literb

4.92 (0.70)

5.23 (1.19)

4.55 (0.37)

5.05 (0.95)

0.78

Blood leukocytes, Cells Ă— 109/Lb

5.43 (1.16)

5.70 (0.52)

5.10 (0.62)

5.70 (1.60)

0.85

  1. Values are expressed as aMedian (Range), bMean ± SD, and analyzed by One-Way ANOVA. Abbreviations: NP nanoparticles, FEV 1 forced expiratory volume in 1 s